Antimicrobial peptides and derived metapeptides
View Patent ↗The peptides and derivative metapeptides based upon natural antimicrobial peptides have potent and broad spectrum activity against pathogens exhibiting multiple antibiotic resistance. Specific peptides can also potentiate the antimicrobial functions of leukocytes, such as neutrophils. In addition, they exhibit lower inherent mammalian cell toxicities than conventional antimicrobial peptides, and overcome problems of toxicity, immunogenicity, and shortness of duration of effectiveness due to biodegradation, retaining activity in plasma and serum. The peptides and derivative metapeptides exhibit rapid microbicidal activities in vitro, can be used to potentiate conventional antimicrobial agents, to potentiate other antimicrobial peptides, and are active against many organisms that exhibit resistance to multiple antibiotics currently in existence.
1. An isolated antimicrobial peptide, consisting of an amino acid sequence of 13 to 74 amino acids with a 7 amino acid core sequence: aa1-aa2-aa3-aa4-aa5-aa6-aa7, wherein aa1 is the amino-terminus of the core sequence and is selected from the group consisting of alanine, lysine and glycine; aa2 is selected from the group consisting of leucine and arginine; aa3 is tyrosine; aa4 and aa5 are selected from the group consisting of lysine, arginine, and histidine; and one of aa6 and aa7 is selected from the group consisting of phenylalanine, tryptophan and tyrosine, such that when aa6 is phenylalanine aa7 is selected from the group consisting of lysine, arginine and histidine, when aa6 is tryptophan aa7 is lysine, and when aa7 is phenylalanine aa6 is leucine; and a modified antimicrobial peptide with the amino acids in said 7 amino acid core sequence modified and retaining antimicrobial activity, wherein said modified amino acids are selected from the group consisting of N-epsilon-monomethyl-lysine, beta branched amino acids, N-methyl amino acids, alpha, beta-dehydro amino acids, and fluorinated amino acids.
2. The antimicrobial peptide according to claim 1 , wherein aa4 and aa5 are selected from the group consisting of lysine and arginine.
3. The antimicrobial peptide according to claim 1 comprising the amino acid sequence as set forth in SEQ ID NO:3.
4. The antimicrobial peptide according to claim 1 comprising the amino acid sequence as set forth in SEQ ID NO:4.
5. The antimicrobial peptide according to claim 1 comprising the amino acid sequence as set forth in SEQ ID NO:5.
6. The antimicrobial peptide according to claim 1 comprising the amino acid sequence as set forth in SEQ ID NO:6.
7. The antimicrobial peptide according to claim 1 comprising the amino acid sequence as set forth in SEQ ID NO:7.
8. The antimicrobial peptide according to claim 1 comprising the amino acid sequence as set forth in SEQ ID NO:8.
9. The antimicrobial peptide according to claim 1 comprising the amino acid sequence as set forth in SEQ ID NO:9.
10. The antimicrobial peptide according to claim 1 comprising the amino acid sequence as set forth in SEQ ID NO:10.
11. The antimicrobial peptide according to claim 1 comprising the amino acid sequence as set forth in SEQ ID NO:11.
12. The antimicrobial peptide according to claim 1 comprising the amino acid sequence as set forth in SEQ ID NO:12.
13. The antimicrobial peptide according to claim 1 comprising the amino acid sequence as set forth in SEQ ID NO:13.
14. The antimicrobial peptide according to claim 1 , wherein said modified amino acids comprise N-epsilon-monomethyl-lysine.
15. The antimicrobial peptide according to claim 1 , wherein said modified amino acids comprise beta branched amino acids.
16. The antimicrobial peptide according to claim 1 , wherein said modified amino acids comprise N-methyl amino acids.
17. The antimicrobial peptide according to claim 1 , wherein said modified amino acids comprise alpha, beta-dehydro amino acids.
18. The antimicrobial peptide according to claim 1 , wherein said modified amino acids comprise fluorinated amino acids.